Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026

Time-Restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome (TimeMAP)

Floyd R, Dyer A, Gibney J, Alawami F, Owens L, Phelan N, Rakovac A, Swan P, LeRoux CW, Behan LA, Duggan SN

Clinical endocrinology · 1 cita

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
Queen's University Belfast
Universidad u hospital
Queen's University
Organización sin fines de lucro
Meath Foundation
Organización sin fines de lucro
The Meath Foundation

Según 4 financiadores declarados.

Publicación

Publicado
2026-01-14 · Clin Endocrinol (Oxf) · vol. 104 · número 4 · págs. 327–342
Editorial
Wiley
Citado
2 citas · más que el 96% de estudios similares · 8.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
54 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC-ND
Áreas de investigación
Dietary Effects on Health · Ovarian function and disorders · Enhanced Recovery After Surgery
Palabras clave
time-restricted eating, polycystic ovary syndrome, hyperinsulinemia, insulin resistance, HbA1c, weight loss, anthropometric indices, dietary intervention, intervention feasibility, crossover design
MeSH
humans, polycystic ovary syndrome, insulin resistance, insulin, blood glucose, cross-over studies, patient compliance, adult, female, young adult, intermittent fasting

11 autores

  • Ruairí Floyd🇮🇪 · autor de correspondenciaTrinity College Dublin; Tallaght University Hospital
  • Adam Dyer🇮🇪Trinity College Dublin
  • James Gibney🇮🇪Trinity College Dublin; Tallaght University Hospital
  • Fatimah Alawami🇮🇪Tallaght University Hospital
  • Lisa Ann Owens🇮🇪Trinity College Dublin; St. James's Hospital
  • Niamh Phelan🇮🇪Trinity College Dublin; St. James's Hospital
  • Ana Rakovac🇮🇪Tallaght University Hospital
  • Patrick Swan🇮🇪University College Dublin
  • Carel Wynand le Roux🇮🇪University College Dublin
  • Lucy‐Ann Behan🇮🇪Trinity College Dublin; Tallaght University Hospital
  • Sinead Noelle Duggan🇬🇧Queen's University Belfast

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

Time-restricted eating (TRE) represents a novel intervention that may improve hyperinsulinaemia and reduce weight, but has not been studied in polycystic ovarian syndrome (PCOS). In a randomised interventional study (NCT05126199 [1]), we investigated the feasibility of TRE in PCOS including recruitment, compliance, safety, drop-out rate, and effect on insulin-related parameters, anthropometrics, nutritional intake and metabolic indices.

Methods

Participants were randomised to a 12-week TRE regimen (18 h fast/6 h eating window) or 'ad libitum' regimen (no time-restriction), and then crossed over to the alternative regimen for a further 12 weeks.

Results

TRE was a feasible intervention with near-total compliance in those completing the intervention; however, there were considerable difficulties with recruitment. A total of 70 were eligible to participate, of which ultimately 15 were recruited, and 11 completed the study (4 [27%] drop-outs due to commitment/study duration). There were no serious adverse events in the TRE group. Compliance [%(SD)] with TRE was 94.7(4.5)%, and 10 participants were keen to continue the intervention post-study. Whilst the study was not powered to detect changes in metabolic or anthropometric indices, exploratory analysis showed a decrease in HbA1c (p = 0.04), weight (p = 0.001), BMI (p = 0.001), hip circumference (p = 0.05) and waist circumference (p = 0.001) in the TRE group compared to the ad libitum eating group.

Conclusion

In a 12-week cross-over feasibility study, TRE was a safe and feasible intervention. Recruitment was challenging and with limited numbers, the TRE group showed a decrease in HbA1c and anthropometric indices compared to the 'ad libitum' group.

Trial registration

NCT05126199.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.